"Beacon Health System currently has visitor restrictions in place for our hospitals and outpatient centers to help minimize the risk of COVID-19 (coronavirus) to our patients. Get the most up-to-date restrictions on our website. Beacon Health System provides care to more than 4,000 patients each day in northern Indiana and southern Michigan. As a not-for-profit, community-governed health system, we target an annual operating income of 4% from our operations. This operating income balances the healthcare needs of the community with the ability to reinvest in the facilities, equipment and talented clinical providers."

During the past decade, Beacon Health System conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beacon Health System" #1 sponsor was "Aadi Bioscience, Inc." with 1 trials, followed by "Beacon Health System" with 1 trials sponsored, "Calithera Biosciences, Inc" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Tempus Labs" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beacon Health System" #1 collaborator was "Beacon Health Foundation" with 1 trials as a collaborator, "Coach Me Health" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Beacon Health System" are "Metastatic Cancer" (2 trials), "Solid Tumor" (2 trials), "Advanced Cancer" (1 trials), "Advanced Solid Tumor" (1 trials) and "Breast Tumor" (1 trials). Many other conditions were trialed in "Beacon Health System" in a lesser frequency.

Most popular intervention types in "Beacon Health System" are "Drug" (4 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin Chemotherapy" (1 trials), "Dexamethasone 4 mg" (1 trials), "Folic acid 400 -1000 μg" (1 trials), "Niraparib" (1 trials) and "Osimertinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beacon Health System" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Beacon Health System". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Beacon Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beacon Health System, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".